Anzeige
Meldung des Tages: Diese Gold-Aktie erzielt in der Tiefe höhere Gehalte: 90 Meter Gold – mögliche Feeder-Zone entdeckt

Sophia Genetics Aktie News

Aktie
WKN:  A3CVT8 ISIN:  CH1125843347 US-Symbol:  SOPH Branche:  Gesundheitswesen: Anbieter u. Dienstleister Land:  Schweiz
4,56 $
-0,05 $
-1,08%
3,8677 € 24.02.26
Depot/Watchlist
Marktkapitalisierung *
271,54 Mio. €
Streubesitz
43,93%
KGV
-3,28
Index-Zuordnung
-

Sophia Genetics News

17.02.26 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026
SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 PR Newswire
10.02.26 - PR Newswire
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems
SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems PR Newswire
12.01.26 - PR Newswire
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan PR Newswire
12.01.26 - PR Newswire
SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der Geschäftsführung an
SOPHiA GENETICS gibt vorläufige Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2025 bekannt, veröffentlicht Prognose für 2026 und kündigt Plan für Wechsel in der ...
12.01.26 - PR Newswire
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan
SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan PR Newswire
07.01.26 - PR Newswire
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology
SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology PR Newswire
12.12.25 - PR Newswire
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine
SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine PR Newswire
11.11.25 - PR Newswire
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine
SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine PR Newswire
04.11.25 - PR Newswire
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance PR Newswire
21.10.25 - PR Newswire
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 PR Newswire
17.10.25 - PR Newswire
A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben
A.D.A.M. Innovations und SOPHiA GENETICS kooperieren, um Flüssigbiopsie-​Tests und Begleitdiagnostik für Präzisionsonkologie in Japan voranzutreiben PR Newswire
16.10.25 - PR Newswire
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan PR Newswire
16.10.25 - PR Newswire
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan PR Newswire
16.10.25 - PR Newswire
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
SOPHiA GENETICS Launches AI-​Powered Digital Twins to Enhance Intelligent Decision-​Making in Oncology PR Newswire
23.09.25 - PR Newswire
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy PR Newswire
23.09.25 - PR Newswire
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy PR Newswire
22.09.25 - PR Newswire
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer PR Newswire
22.09.25 - PR Newswire
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer PR Newswire

Newssuche

Videos

newspaper
18.02.26 +6,11%
Technical Trading: Chance mit 82 Prozent Treffern
Rohöl Long Typ: Turbo Open End WKN: VH65XQ Hebel:6 Laufzeit: OpenEnd Einstieg: Market ... Mehr »